Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis

Veterinary Parasitology

Volumn 77, Issue 1, 1998, Pages 71-73

  Vexenat, J A ^a   Croft, S L ^b   Furtado Campos, J H ^c   Miles, M A ^b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

Author keywords

Buparvaquone; Control methods Protozoa; Dog; Leishmania donovani; Leishmania infantum Leishmania chagasi

Indexed keywords

BUPARVAQUONE;

ANIMAL EXPERIMENT; ANIMAL PARASITOSIS; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE COURSE; DOG; FEMALE; HAIR GROWTH; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; MALE; NONHUMAN; TREATMENT FAILURE; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; DOG DISEASES; DOGS; FEMALE; INJECTIONS, INTRAMUSCULAR; LEISHMANIASIS, VISCERAL; MALE; NAPHTHOQUINONES;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA DONOVANI; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA INFANTUM; PROTOZOA;

EID: 0031750416     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(96)01150-8     Document Type: Article

References (9)

1. Croft S.L., Hogg J., Gutteridge W.E., Hudson A.T., Randall A.W. The activity of hydroxynaphthoquinones against Leishmania donovani. J. Antimicrob. Chemother. 30:1992;827-832.
2. de Gorgolas M., Miles M.A. Visceral leishmaniasis and AIDS. Nature. 372:1994;734.
3. Gramiccia M., Gradoni L., Orsini S. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann. Trop. Med. Parasitol. 86:1992;613-620.
4. Hudson A.T., Randall A.W., Fry M., Ginger C.D., Hill B., Latter V.S., McHardy N., Williams R.B. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Parasitology. 90:1985;45-55.
5. Kassai T., Cordero del Campillo M., Euzeby J., Gaafar S., Hiepe Th., Himonas C.A. Standardized nomenclature of animal parasitic diseases (SNOAPAD). Vet. Parasitol. 29:1988;299-326.
6. McHardy, N., 1992. Butalex (buparvaquone): a new therapeutic for theileriosis. In: T.T. Dolan (Ed.), Recent Developments in the Research and Control of Theileria annulata; Proceedings of a Workshop held at ILRAD, Nairobi, Kenya, 17-19 September 1990. International Laboratory for Research on Animal Diseases, Nairobi.
7. Oliva G., Gradoni L., Ciaramella P., De Luna R., Cortese L., Orsini S., Davidson R.N., Persechino A. Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. J. Antimicrob. Chemother. 36:1995;1013-1019.
8. Vexenat J.A., de Castro J.A.F., Cavalcante R., Tavares J.P., da Silva M.R.B., Batista W.H., Campos J.H.F., Howard M.K., Frame I., McNerney R., Wilson S., Miles M.A. Visceral leishmaniasis in Teresina, State of Piaui, Brazil: preliminary observations on the detection and transmissibility of canine and sandfly infections. Mem. Inst. Oswaldo Cruz. 89:1994;131-135.
9. Vexenat, J.A., Olliaro, P.L., Fonseca de Castro, J.A., Cavalcante, R., Furtado Campos, J.H., Tavares, J.P., Miles, M.A., 1998. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin). Am. J. Trop. Med. Hyg. (in press).